Since CaMKII has emerged as a procardiomyopathic signal [2], [26]–[31], our goal was to determine whether CaMKII inhibition has a protective role in a severe form of cardiomyopathy due to impairment of CaM inhibition of RyR2. Here, RYR2 is linked to cardiomyopathy.